Currently in shortage

Gilead USA manufacturing site upgrade causing temporary reduced output. HIV medicines are critical — do NOT interrupt therapy.

Expected resolution: 31 August 2025

Alternatives:

bictegravir + emtricitabine + tenofovir alafenamide

Biktarvy

50/200/25 mg · tablet · HIV

PBS Pricing

General patient co-payment$31.60
Concession co-payment$7.70
Full dispensed price$1,248.00

PBS Information

Item code
ANV007
Drug name
bictegravir + emtricitabine + tenofovir alafenamide
Brand name
Biktarvy
Manufacturer
Gilead
Formulation
tablet
Strength
50/200/25 mg
Max quantity
30 units
Max repeats
5
PBS listed
Yes
Therapeutic group
HIV

TGA Reference: TGA-MSI-2025-040 · Sponsor: Gilead Sciences Pty Ltd

MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.